Science news articles about 'montelukast'

... predict even more precisely which patients will benefit from montelukast. “These findings will help doctors know in advance ... leukotrienes, which contribute to inflammation. However, physicians have found that montelukast is quite variable in its effectiveness, helping some patients ...

... , other leukotriene receptor antagonists, e.g. montelukast (SingulairTM) and zafirlukast (AccolateTM) can suppress MRP ...

... out the top five were warfarin, escitalopram, risperidone and montelukast. The most common off-label use for six of the 14 ...

... responded best to the leukotriene receptor antagonist montelukast, and 27 responded best to doubling the dose ... best to LABA step-up or corticosteroid step-up, but not the montelukast. The addition of LABA step-up therapy was most likely ...

... responded best to the leukotriene receptor antagonist montelukast, and 27 responded best to doubling the dose ...

... - sold under the brand names 'Singulair' (montelukast) and 'Accolate' (zafirlukast) – have long been on the market as an alternative ...